At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IVA Inventiva S.A.
Trading 11-22 10:06:38 EST
2.58
-0.02
-0.77%
High2.59Low2.55Vol6.34K
Open2.56D1 Closing2.60Amplitude1.53%
Mkt Cap224.66MTradable Cap46.89MTotal Shares87.08M
T/O16.39KT/O Rate0.03%Tradable Shares18.17M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Inventiva S.A reports 9M results
seekingalpha  ·  05:51
Inventiva S.A reports 9M results
Inventiva’s Financial Position and Future Prospects
TIPRANKS  ·  05:47
Inventiva’s Financial Position and Future Prospects
Inventiva Reports Revenues Of €1.3 Million For The First 9-Months Of 2024
Benzinga  ·  05:16
Inventiva Reports Revenues Of €1.3 Million For The First 9-Months Of 2024
Inventiva reports 2024 Third Quarter Financial Information¹
GlobeNewswire  ·  05:00
Inventiva reports 2024 Third Quarter Financial Information¹
Inventiva Reports Voting Rights and Advances Clinical Trials
TIPRANKS  ·  11-21 05:54
Inventiva Reports Voting Rights and Advances Clinical Trials
Inventiva Prepares for Key General Meeting and Financing Plans
TIPRANKS  ·  11-21 05:54
Inventiva Prepares for Key General Meeting and Financing Plans
Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
GlobeNewswire  ·  11-21 05:00
Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
Five9, Inc (FIVN) Expands AI Suite: Next-Gen AI Agents Revolutionize Customer Experience
Insider Monkey  ·  11-21 01:52
Five9, Inc (FIVN) Expands AI Suite: Next-Gen AI Agents Revolutionize Customer Experience
Travel Services Company Deploys Verint AI-Powered Self-Service, Driving $10 Million Annual Savings
Business Wire  ·  11-19
Travel Services Company Deploys Verint AI-Powered Self-Service, Driving $10 Million Annual Savings
Alight to Enhance the Employee Experience with Launch of Alight Worklife® on Microsoft Teams
Business Wire  ·  11-18
Alight to Enhance the Employee Experience with Launch of Alight Worklife® on Microsoft Teams
Inventiva’s Phase 2 Results Boost Hope for MASH Treatment
TIPRANKS  ·  11-16
Inventiva’s Phase 2 Results Boost Hope for MASH Treatment
Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
GlobeNewswire  ·  11-16
Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
Verint Systems Inc. (VRNT): Transforming Customer Engagement with AI, Saving $10.5 Million Annually for a Leading Telecom Company
Insider Monkey  ·  11-14
Verint Systems Inc. (VRNT): Transforming Customer Engagement with AI, Saving $10.5 Million Annually for a Leading Telecom Company
Five9 Unveils AI Agents to Redefine Hyper-Personalized Self-Service CX
Business Wire  ·  11-13
Five9 Unveils AI Agents to Redefine Hyper-Personalized Self-Service CX
Inventiva Sa : UBS Initiates Coverage With Neutral Rating; Price Target $3
THOMSON REUTERS  ·  11-12
Inventiva Sa : UBS Initiates Coverage With Neutral Rating; Price Target $3
Top Telecommunications Company Reports $10.5 Million Annual Savings from Verint AI-Powered Voice Self-Service
Business Wire  ·  11-11
Top Telecommunications Company Reports $10.5 Million Annual Savings from Verint AI-Powered Voice Self-Service
Inventiva’s Strategic Moves at Upcoming General Meeting
TIPRANKS  ·  11-04
Inventiva’s Strategic Moves at Upcoming General Meeting
Inventiva Gains Positive Nod for Lanifibranor Trial
TIPRANKS  ·  10-31
Inventiva Gains Positive Nod for Lanifibranor Trial
Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
GlobeNewswire  ·  10-31
Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
TRU Recognition emerges as a key player in booming intelligent video analytics market
Stockheads  ·  10-23
TRU Recognition emerges as a key player in booming intelligent video analytics market

Introduction

Company Name.
Inventiva S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
Issue price:
--